Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux, France. Richaud@bergonie.org
Several adjuvant treatments are used after radical prostatectomy. In case of local risk of recurrence, adjuvant radiotherapy decreases the risk of biochemical recurrence but does not improve the overall survival. In case of metastasis risk, adjuvant hormone therapy should be discussed. For positive lymph node patients, LHRH agonists after radical prostatectomy improve overall survival. For pT3 patients with positive surgical margins, non steroid anti androgens improve disease free survival.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on